What Is the Optimal Antithrombotic Therapy for Valsalva Thrombus Following Transcatheter Aortic Valve Replacement?
Thrombus formation between the native sinus of Valsalva and the implanted transcatheter heart valve is a rare complication that may be associated with an increased risk for thrombotic complications. This paper presents the course of 3 cases with Valsalva thrombus, with a focus on the management of antithrombotic therapy.
Authors
- Makoto Sugihara (ORCID: https://orcid.org/0000-0002-0103-9260)
- Shin‐ichiro Miura (ORCID: https://orcid.org/0000-0003-4904-0217)
- Tetsuo Hirata (ORCID: https://orcid.org/0000-0001-9671-2333)
- Yuto Kawahira
- Yuta Kato (ORCID: https://orcid.org/0000-0002-8319-487X)
- Go Kuwahara
- Midori Miyazaki
Institutions
- Fukuoka University Hospital (JP)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1016/j.jaccas.2024.102455
- Citations
- 1
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.39